The company have significantly boosted its course of the innovative solution for cardiac amyloidosis, employing the compound. Early trial information suggests significant benefits for patients diagnosed from this https://attr-cm982116.blogdon.net/bridgebio-progresses-cardiac-amyloidosis-management-with-attruby-58313214